ClinicalTrials.Veeva

Menu

Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome (ParvoPre)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Pregnancy
Parvovirus B19 Infection

Treatments

Other: Collection of clinical data.

Study type

Observational

Funder types

Other

Identifiers

NCT07338279
ParvoPre

Details and patient eligibility

About

The goal of this observational study is to define the rate of intrauterine parvovirus B19 infection and fetal/newborn complications after parvovirus B19 infection of pregnant women. Secondary objectives are risk factors, pregnancy outcomes, long-term sequelae and efficacy of the management interventions.

Enrollment

150 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women >18 years with parvovirus B19 infection and their neonates.

Exclusion criteria

  • None

Trial contacts and locations

5

Loading...

Central trial contact

Daniele Lilleri

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems